We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FPH:NYSEFive Point Holdings, LLC Analysis

Data as of 2026-06-13 - not real-time

$5.16

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Five Point Holdings trades around $5.16, comfortably above its 20‑day and 50‑day SMAs (~$4.98) but still below the 200‑day SMA (~$5.52), indicating a short‑term price lift within a longer‑term downtrend. The MACD histogram is positive and the MACD line sits above its signal, suggesting momentary bullish momentum, while the RSI at 59 points to neither overbought nor oversold conditions. Valuation metrics are compelling: the trailing P/E of 8.5 is far below the industry average of 33.4, and the price‑to‑book ratio of 0.44 signals a deep discount to book value. However, the balance sheet is strained – a debt‑to‑equity ratio of nearly 20 and total debt exceeding cash by $140 M raise solvency concerns, especially given a -70% operating margin. Operating cash flow remains modestly positive at $4 M, yet free cash flow is heavily negative, reflecting sizable capital expenditures. The stock’s 30‑day volatility of 27% and a decreasing volume trend add to the near‑term uncertainty, while the Fear & Greed Index’s “Extreme Greed” reading hints at heightened market optimism that may be premature.
Given the mix of cheap valuation, high leverage, and mixed technical signals, the outlook leans toward cautious positioning: short‑term price action may be constrained by bearish trend and liquidity pressure, but the long‑run upside could materialize if the company stabilizes margins and reduces debt. Investors should monitor cash‑flow trends, debt repayment progress, and any macro‑economic shifts in the California real estate market before committing significant capital.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD but overall bearish trend
  • Decreasing volume and high short‑term volatility
  • Price near immediate resistance at $5.22

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Significant valuation discount (P/E 8.5 vs industry 33.4)
  • Potential for margin improvement and debt reduction
  • Strong cash position relative to market cap

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High leverage (debt‑to‑equity ~20) limits upside
  • Exposure to California real‑estate cycles
  • Absence of dividend and modest ROE (~5%)

Key Metrics & Analysis

Financial Health

Revenue Growth3.20%
Profit Margin41.16%
P/E Ratio8.5
ROE5.11%
ROA-0.21%
Debt/Equity19.84
P/B Ratio0.4
Op. Cash Flow$4.0M
Free Cash Flow$-125328624
Industry P/E33.4

Technical Analysis

TrendBearish
RSI59.1
Support$4.60
Resistance$5.22
MA 20$4.98
MA 50$4.98
MA 200$5.52
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

GradeUndervalued
TypeBlend

Risk Assessment

Beta0.79
Volatility27.45%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.